The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis

被引:96
|
作者
Hakem, A
Sasaki, T
Kozieradzki, I
Penninger, JM
机构
[1] Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada
[2] Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1999年 / 189卷 / 06期
关键词
cyclin-dependent kinase 2; apoptosis; cell cycle; thymocyte;
D O I
10.1084/jem.189.6.957
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aberrant activation of cell cycle molecules has been postulated to play a role in apoptosis ("catastrophic cell. cycle"). Here we show that in noncycling developing thymocytes, the cyclin-dependent kinase Cdk2 is activated in response to all specific and nonspecific apoptotic stimuli tested, including peptide-specific thymocyte apoptosis. Cdk2 was found to function upstream of the tumor suppressor p53, transactivation of the death promoter Bar, alterations of mitochondrial permeability, Bcl-2, caspase activation, and caspase-dependent proteolytic cleavage of the retinoblastoma protein. Inhibition of Cdk2 completely protected thymocytes from apoptosis, mitochondrial changes, and caspase activation. These data provide the first evidence that Cdk2 activity is crucial for the induction of thymocyte apoptosis.
引用
收藏
页码:957 / 967
页数:11
相关论文
共 50 条
  • [1] A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma
    Liu, Hengrui
    Weng, Jieling
    GENE, 2022, 822
  • [2] Inhibition of the cyclin-dependent kinase CDK2 induces hypertrophy in cardiac myocytes
    Bril, A
    Rouanet, S
    Berrebi-Bertrand, I
    Meijer, L
    CIRCULATION, 1999, 100 (18) : 627 - 627
  • [3] Transforming growth factor β targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity
    Nagahara, H
    Ezhevsky, SA
    Vocero-Akbani, AM
    Kaldis, P
    Solomon, MJ
    Dowdy, SF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 14961 - 14966
  • [4] Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells
    Matsumoto, Y
    Hayashi, K
    Nishida, E
    CURRENT BIOLOGY, 1999, 9 (08) : 429 - 432
  • [5] Discovery of Selective Tertiary Amide Inhibitors of Cyclin-Dependent Kinase 2 (CDK2)
    Zeng, Mingshuo
    Grandner, Jessica M.
    Bryan, Marian C.
    Verma, Vishal
    Larouche-Gauthier, Robin
    Leclerc, Jean-Philippe
    Zhao, Liang
    Haghshenas, Pouyan
    Aubert-Nicol, Samuel
    Yadav, Arun
    Ashley, Melissa
    Chen, Jacob Z.
    Durk, Matthew
    Samy, Karen E.
    Nespi, Marika
    Levy, Elizabeth
    Merrick, Karl
    Moffat, John G.
    Murray, Jeremy
    Oh, Angela
    Orr, Christine
    Segal, Ehud
    Sims, Jessica
    Sneeringer, Christopher
    Prangley, Madeleine
    Vartanian, Steffan
    Magnuson, Steven
    Parr, Brendan T.
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (09): : 1179 - 1187
  • [6] Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2
    Morisaki, H
    Fujimoto, A
    Ando, A
    Nagata, Y
    Ikeda, K
    Nakanishi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (02) : 386 - 390
  • [7] Phosphorylation of MCM3 Protein by Cyclin E/Cyclin-dependent Kinase 2 (Cdk2) Regulates Its Function in Cell Cycle
    Li, Junhui
    Deng, Min
    Wei, Qian
    Liu, Ting
    Tong, Xiaomei
    Ye, Xin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (46) : 39776 - 39785
  • [8] CYCLIN-DEPENDENT KINASE-2 (CDK2) IN THE MURINE CDC2 KINASE TS MUTANT
    YASUDA, H
    NAKATA, T
    KAMIJO, M
    HONDA, R
    NAKAMURA, M
    NINOMIYATSUJI, J
    YAMASHITA, M
    NAGAHAMA, Y
    OHBA, Y
    SOMATIC CELL AND MOLECULAR GENETICS, 1992, 18 (05) : 403 - 408
  • [9] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Gitig, DM
    Koff, A
    MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 179 - 188
  • [10] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Diana M. Gitig
    Andrew Koff
    Molecular Biotechnology, 2001, 19 : 179 - 188